Jonah Comstock

JPM: Is it the calm before the storm for radiotherapeutics? Radioligand therapies, which deliver small amounts of radioactive isotopes directly to cancer cells, are still waiting for their breakthrough moment. The technology has tremendous potential to de... See more

Is this the year for precision psychology? With Amit Etkin A quiet paradigm shift is underway in neuroscience as the industry begins to accept the idea of precision psychology – that is, using stronger data and better biomarkers to develop more effective ... See more

NVIDIA announces Lilly, Thermo Fisher collaborations at JPM Global chipmaker giant NVIDIA kicked off JPM Week with several partnership announcements, most notably a billion dollar partnership with Indianapolis-based Eli Lilly. "Biology is on the verge of ... See more

NVIDIA announces Lily, Thermo Fisher partnerships at JPM Global chipmaker giant NVIDIA kicked off JPM Week with several partnership announcements, most notably a billion dollar partnership with Indianapolis-based Eli Lilly. "Biology is on the verge of its... See more

Cracking the code: How European biotechs can win in the US market At Frontiers Health 2025, Mike Ryan, General Manager Europe at EVERSANA, tackled one of the most pressing questions for emerging pharma and biotech companies: how to successfully launch in ... See more